top of page

Organotropism in Breast Cancer Metastasis: How the Pre-Metastatic Niche Shapes Organ-Specific Spread

Arya Aditya Shiralkar
21/11/26

Metastasis is a major cause of mortality in patients with advanced breast cancer and is influenced by the ability of tumor cells to establish supportive microenvironments in distant organs. A major contributor to metastatic progression is the formation of the pre-metastatic niche (PMN), in which distant organs are remodeled before the arrival of metastatic cells. This process represents a potential window for therapeutic intervention before the establishment of metastatic disease. This review synthesizes information from primary studies and literature reviews to analyze how the primary tumor uses exosomes and other secreted factors to develop organ-specific PMNs by remodeling their microenvironments. We highlight evidence that organotropism is influenced by the molecular composition of tumor-derived exosomes, including their integrin profiles, which can promote interactions with specific target organs. Exosomal contents such as lncRNAs and secreted growth factors can also activate resident fibroblasts and promote extracellular matrix remodeling, including changes in collagen deposition and cross-linking. In parallel, tumor-derived factors can reprogram myeloid-derived suppressor cells, neutrophils, and T-cells to create an immunosuppressive environment, while distinct exosomal miRNAs, lncRNAs, and proteins can promote angiogenesis and alter vascular permeability. Together, these mechanisms demonstrate that PMN formation is not a single pathway but involves coordinated changes across multiple cellular and molecular components in distant organs. Where mechanisms discussed occur after tumor-cell arrival rather than before, this distinction is marked explicitly. These findings also highlight the potential of circulating exosomal cargo as a source of biomarkers for early detection of metastatic risk and identification of organ-specific molecular signatures, although most mechanisms reviewed derive from preclinical models, and substantial clinical validation is required before such approaches can be applied in practice.

bottom of page